Skip to main content
Clinical Trials/NCT06364618
NCT06364618
Not yet recruiting
Not Applicable

Use of Continuous Biomonitoring for Detection of Infectious Complications in Kidney Transplant Recipients

Institute for Clinical and Experimental Medicine1 site in 1 country200 target enrollmentSeptember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Transplant Infection
Sponsor
Institute for Clinical and Experimental Medicine
Enrollment
200
Locations
1
Primary Endpoint
Accuracy of the algorithm at detecting infections at presymptomatic stage
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to develop a machine learning algorithm for early detection of infections in kidney transplant recipients using data recorded by wearable digital health technologies.

The main questions it aims to answer are:

  1. What are the biometric data pattern changes in impending infections?
  2. What accuracy the machine learning algorithm can achieve?

Participants will be given/use their own wearable device that will record biometric data. Any infection event will be recorded and an algorithm will be trained to recognize changes in biometric data preceding symptomatic infection.

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
December 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Institute for Clinical and Experimental Medicine
Responsible Party
Principal Investigator
Principal Investigator

Prof. Ondřej Viklický, M.D., Ph.D.

Head of Transplantation Center, Principal Investigator

Institute for Clinical and Experimental Medicine

Eligibility Criteria

Inclusion Criteria

  • kidney transplant recipient
  • age 18 years or more
  • kidney allograft function (eGFR based on CKD-EPI more than 15ml/min/1.73m2)

Exclusion Criteria

  • recipient of another transplanted organ
  • terminal failure of another organ (heart, liver, lung)
  • diabetes mellitus type 1
  • pregnant or breastfeeding woman
  • refusal to give informed consent

Outcomes

Primary Outcomes

Accuracy of the algorithm at detecting infections at presymptomatic stage

Time Frame: The primary endpoint will be assessed periodically throughout the study, up to 24 months.

Accuracy, sensitivity, specificity, negative and positive predictive value of the machine learning algorithm at detecting infections in presymptomatic stage in kidney transplant recipients.

Study Sites (1)

Loading locations...

Similar Trials